Literature DB >> 22854883

Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study.

Edmund Luke Gomez1, Suk Chyn Gun, Sushela Devi Somanath, Karuthan Chinna, Ammu K Radhakrishnan.   

Abstract

OBJECTIVES: The prognostic significance of rheumatoid factor (RF) and anticyclic citrullinated peptide antibody (anti-CCP) in rheumatoid arthritis (RA) remains contentious due to the conflicting lines of evidence. This study aims to determine the association between RF isotypes and anti-CCP with disease severity in RA patients from three ethnic groups.
METHODS: A total of 147 RA patients from three different ethnic groups (Malays, Chinese, and Indians) who fulfilled the 1987 American College of Rheumatology (ACR) revised criteria for RA were recruited into this study. The seroprevalence of RF isotypes immunoglobulin (Ig)A, IgG, and IgM, as well as anti-CCP was determined using commercial enzyme-linked immunosorbent assay (ELISA) kits. Multinomial regression analysis was performed to assess the independent effects of autoantibody status on the development of deforming and erosive RA and the presence of extra-articular manifestations (EAM).
RESULTS: In Chinese patients, we found a significant association (p < 0.05) between IgG RF and anti-CCP and the presence of erosive disease, as well as IgM RF and IgG RF with the presence of joint deformities. In Indian patients, IgM RF was associated with deforming disease, whereas none of the antibodies were associated with disease severity in Malay patients. Multinomial regression analysis revealed that IgG RF was the most important predictor variable for erosive disease in Chinese patients, and IgM RF the only predictor variable associated with deforming disease in both Chinese and Indian RA patients.
CONCLUSIONS: There is variability in the phenotypic association of RF isotypes and anti-CCP in relation to disease severity of RA in the three ethnic groups. RF, in particular, IgG and IgM, may be better prognosticators of severe disease in Chinese and Indian patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854883     DOI: 10.1007/s10165-012-0718-6

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

1.  Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing.

Authors:  Miriam Lizette Díaz-Toscano; Eva Maria Olivas-Flores; Soraya Amali Zavaleta-Muñiz; Jorge Ivan Gamez-Nava; Ernesto German Cardona-Muñoz; Manuel Ponce-Guarneros; Uriel Castro-Contreras; Arnulfo Nava; Mario Salazar-Paramo; Alfredo Celis; Nicte Selene Fajardo-Robledo; Esther Guadalupe Corona-Sanchez; Laura Gonzalez-Lopez
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

2.  Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor.

Authors:  Maizatul A Othman; Wan Syamimee W Ghazali; Wan Zuraida W A Hamid; Kah K Wong; Nurul K Yahya
Journal:  Saudi Med J       Date:  2017-09       Impact factor: 1.484

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.